ivan Bodis-Wollner - Publications

Affiliations: 
State University of New York (SUNY) 
Area:
visual system,dopamine , Parkinson disease

181 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Miri S, Glazman S, Mylin L, Bodis-Wollner I. A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease. Parkinsonism & Related Disorders. PMID 26414119 DOI: 10.1016/j.parkreldis.2015.09.015  0.32
2015 Slotnick S, Ding Y, Glazman S, Durbin M, Miri S, Selesnick I, Sherman J, Bodis-Wollner I. A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1692-5. PMID 26340519 DOI: 10.1002/mds.26411  0.32
2015 Westheimer O, McRae C, Henchcliffe C, Fesharaki A, Glazman S, Ene H, Bodis-Wollner I. Dance for PD: a preliminary investigation of effects on motor function and quality of life among persons with Parkinson's disease (PD). Journal of Neural Transmission (Vienna, Austria : 1996). PMID 25836752 DOI: 10.1007/s00702-015-1380-x  0.32
2015 Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, et al. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. Jama. 313: 584-93. PMID 25668262 DOI: 10.1001/jama.2015.120  0.32
2015 Fang JY, Pérez A, Christine CW, Leehey M, Aminoff MJ, Boyd JT, Morgan JC, Dhall R, Nicholas AP, Bodis-Wollner I, Zweig RM, Goudreau JL. Parkinson's disease severity and use of dopaminergic medications. Parkinsonism & Related Disorders. 21: 297-9. PMID 25541182 DOI: 10.1016/j.parkreldis.2014.10.016  0.32
2015 Sabari JS, Ortiz D, Pallatto K, Yagerman J, Glazman S, Bodis-Wollner I. Activity engagement and health quality of life in people with Parkinson's disease. Disability and Rehabilitation. 37: 1411-5. PMID 25332087 DOI: 10.3109/09638288.2014.972588  0.32
2015 Simuni T, Kieburtz K, Tilley B, J Elm J, Ravina B, Babcock D, Emborg M, Hauser R, Kamp C, Morgan JC, Webster Ross G, K Simon D, Bainbridge J, Baker L, Bodis-Wollner I, et al. Pioglitazone in early Parkinson's disease: A phase 2, multicentre, double-blind, randomised trial The Lancet Neurology. 14: 795-803. DOI: 10.1016/S1474-4422(15)00144-1  0.32
2014 Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S. α-synuclein in the inner retina in parkinson disease. Annals of Neurology. 75: 964-6. PMID 24816946 DOI: 10.1002/ana.24182  0.32
2014 Ding Y, Spund B, Glazman S, Shrier EM, Miri S, Selesnick I, Bodis-Wollner I. Application of an OCT data-based mathematical model of the foveal pit in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 1367-76. PMID 24748549 DOI: 10.1007/s00702-014-1214-2  0.32
2014 Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. Jama Neurology. 71: 710-6. PMID 24711047 DOI: 10.1001/jamaneurol.2014.391  0.32
2014 Bodis-Wollner I, Miri S, Glazman S. Venturing into the no-man's land of the retina in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 15-22. PMID 24339212 DOI: 10.1002/mds.25741  0.32
2014 Wu B, Hu X, Wang X, Bodis-Wollner I. Effects of subthalamic nucleus deep brain stimulation on cognitive function in patients with Parkinson's disease Chinese Journal of Neurology. 47: 617-623. DOI: 10.3760/cma.j.issn.1006-7876.2014.09.005  0.32
2013 Adam CR, Shrier E, Ding Y, Glazman S, Bodis-Wollner I. Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 33: 137-42. PMID 23612240 DOI: 10.1097/WNO.0b013e31828c4e1a  0.32
2013 Bodis-Wollner I, Glazman S, Yerram S. Fovea and foveation in Parkinson's disease. Behavioral Neuroscience. 127: 139-50. PMID 23356330 DOI: 10.1037/a0031225  0.32
2013 Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, Bodis-Wollner I. Remodeling of the fovea in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 745-53. PMID 23263598 DOI: 10.1007/s00702-012-0909-5  0.32
2013 Bodis-Wollner I. Foveal vision is impaired in Parkinson's disease. Parkinsonism & Related Disorders. 19: 1-14. PMID 22998939 DOI: 10.1016/j.parkreldis.2012.07.012  0.32
2013 Yerram S, Glazman S, Bodis-Wollner I. Cortical control of saccades in Parkinson disease and essential tremor. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 145-56. PMID 22926662 DOI: 10.1007/s00702-012-0870-3  0.32
2013 Bodis-Wollner I, Antal A. Primary Visual and Visuocognitive Deficits Milestones in Drug Therapy. 24: 317-334. DOI: 10.1007/978-1-60761-429-6_22  0.32
2013 Pfeiffer RF, Bodis-Wollner I. Parkinson's Disease and Nonmotor Dysfunction Current Clinical Neurology. 24. DOI: 10.1007/978-1-60761-429-6  0.32
2013 Pfeiffer RF, Bodis-Wollner I. Preface Current Clinical Neurology. 24: ix-xi.  0.32
2012 Shrier EM, Adam CR, Spund B, Glazman S, Bodis-Wollner I. Interocular asymmetry of foveal thickness in Parkinson disease. Journal of Ophthalmology. 2012: 728457. PMID 22900149 DOI: 10.1155/2012/728457  0.32
2012 Javaid MA, Amassian V, Glazman S, Fesharaki A, Stefanov D, Bodis-Wollner I. Cortical control of voluntary saccades in Parkinson's disease and pre-emptive perception. Parkinsonism & Related Disorders. 18: S100-3. PMID 22166401 DOI: 10.1016/S1353-8020(11)70032-3  0.32
2012 Bodis-Wollner I, Tzelepi A. The Effect of Diverse Dopamine Receptors on Spatial Processing in the Central Retina: A Model Seeing Spatial Form. DOI: 10.1093/acprof:oso/9780195172881.003.0017  0.32
2011 Chou KL, Zamudio J, Schmidt P, Price CC, Parashos SA, Bloem BR, Lyons KE, Christine CW, Pahwa R, Bodis-Wollner I, Oertel WH, Suchowersky O, Aminoff MJ, Malaty IA, Friedman JH, et al. Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers. Parkinsonism & Related Disorders. 17: 440-5. PMID 21458353 DOI: 10.1016/j.parkreldis.2011.03.002  0.32
2011 Aminoff MJ, Christine CW, Friedman JH, Chou KL, Lyons KE, Pahwa R, Bloem BR, Parashos SA, Price CC, Malaty IA, Iansek R, Bodis-Wollner I, Suchowersky O, Oertel WH, Zamudio J, et al. Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism & Related Disorders. 17: 139-45. PMID 21159538 DOI: 10.1016/j.parkreldis.2010.11.009  0.32
2011 Amassian VE, Cracco RQ, MacCabee PJ, Cracco JB, Rudell AP, Eberle L, Bodis-Wollner I. The role of visual perception in spoken responses Biocybernetics and Biomedical Engineering. 31: 65-80.  0.32
2010 Javaid MA, Weeden J, Flom P, Avitable M, Glazman S, Bodis-Wollner I. Perisaccadic gamma modulation in Parkinson disease patients and healthy subjects. Clinical Eeg and Neuroscience. 41: 94-101. PMID 20521492  0.32
2010 Bodis-Wollner I. Current aspects of cognitive neurophysiology of Parkinson disease: an introduction. Clinical Eeg and Neuroscience. 41: 68-75. PMID 20521488  0.32
2010 Bodis-Wollner I. Cognitive neurophysiology of Parkinson disease. Clinical Eeg and Neuroscience. 41: VI. PMID 20521486  0.32
2009 Bodis-Wollner I. Retinopathy in Parkinson Disease. Journal of Neural Transmission (Vienna, Austria : 1996). 116: 1493-501. PMID 19730784 DOI: 10.1007/s00702-009-0292-z  0.32
2009 Parashos SA, Swearingen CJ, Biglan KM, Bodis-Wollner I, Liang GS, Ross GW, Tilley BC, Shulman LM. Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. Archives of Neurology. 66: 1099-104. PMID 19597081 DOI: 10.1001/archneurol.2009.159  0.32
2009 Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, Bodis-Wollner IG. Inner retinal layer thinning in Parkinson disease. Archives of Ophthalmology (Chicago, Ill. : 1960). 127: 737-41. PMID 19506190 DOI: 10.1001/archophthalmol.2009.106  0.32
2009 Bodis-Wollner I, Brannan JR, Storch RL, Hajee ME, Minko M. The effect of background spatial contrast on electroretinographic responses in the human retina. Vision Research. 49: 922-30. PMID 18723047 DOI: 10.1016/j.visres.2008.07.008  0.32
2008 Rieger JW, Kim A, Argyelan M, Farber M, Glazman S, Liebeskind M, Meyer T, Bodis-Wollner I. Cortical functional anatomy of voluntary saccades in Parkinson disease. Clinical Eeg and Neuroscience. 39: 169-74. PMID 19044213  0.32
2008 Rieger JW, Schoenfeld MA, Heinze HJ, Bodis-Wollner I. Different spatial organizations of saccade related BOLD-activation in parietal and striate cortex. Brain Research. 1233: 89-97. PMID 18710650 DOI: 10.1016/j.brainres.2008.07.108  0.32
2008 Bodis-Wollner I. Pre-emptive perception. Perception. 37: 462-78. PMID 18491722 DOI: 10.1068/p5880  0.32
2008 Forgacs PB, von Gizycki H, Selesnick I, Syed NA, Ebrahim K, Avitable M, Amassian V, Lytton W, Bodis-Wollner I. Perisaccadic parietal and occipital gamma power in light and in complete darkness. Perception. 37: 419-32. PMID 18491719 DOI: 10.1068/p5875  0.32
2008 Amassian V, Mari Z, Sagliocco L, Hassan N, Maccabee P, Cracco JB, Cracco RQ, Bodis-Wollner I. Perception of phosphenes and flashed alphabetical characters is enhanced by single-pulse transcranial magnetic stimulation of anterior frontal lobe: the thalamic gate hypothesis. Perception. 37: 375-88. PMID 18491715 DOI: 10.1068/p5948  0.32
2008 Antal A, Terney D, Bodis-Wollner I. Parkinson's disease, aging, and visual cognition Topics in Geriatric Rehabilitation. 24: 166-181. DOI: 10.1097/01.TGR.0000318903.80066.e7  0.32
2008 Bodis-Wollner I. Perception: Introduction Perception. 37: 330-332.  0.32
2006 Bodis-Wollner I, Jo MY. Getting around and communicating with the environment: visual cognition and language in Parkinson's disease. Journal of Neural Transmission. Supplementum. 333-8. PMID 17017549  0.32
2006 Lalli S, Hussain Z, Ayub A, Cracco RQ, Bodis-Wollner I, Amassian VE. Role of the calcarine cortex (V1) in perception of visual cues for saccades. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 117: 2030-8. PMID 16884952 DOI: 10.1016/j.clinph.2006.05.022  0.32
2006 Balazs S, Stepan C, Binder H, von Gizycki H, Avitable M, Obersteiner A, Rattay F, Selesnick I, Bodis-Wollner I. Conjugate eye movements and gamma power modulation of the EEG in persistent vegetative state. Journal of the Neurological Sciences. 246: 65-9. PMID 16580696 DOI: 10.1016/j.jns.2006.02.007  0.32
2006 Forgacs PB, Von Gizycki H, Harhula M, Avitable M, Selesnick I, Bodis-Wollner I. Chapter 25 The wavelet transformed EEG: a new method of trial-by-trial evaluation of saccade-related cortical activity Supplements to Clinical Neurophysiology. 59: 183-189. DOI: 10.1016/S1567-424X(09)70029-7  0.32
2005 Antal A, Bodis-Wollner I, Paulus W. Chapter 25 Visual dysfunction in disorders with altered dopaminergic neurotransmission Handbook of Clinical Neurophysiology. 5: 467-490. DOI: 10.1016/S1567-4231(09)70222-9  0.32
2004 Forgacs PB, Bodis-Wollner I. Nicotinic receptors and cognition in Parkinson's Disease: the importance of neuronal synchrony. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 1317-31. PMID 15480841 DOI: 10.1007/s00702-004-0169-0  0.32
2003 Bodis-Wollner I. Neuropsychological and perceptual defects in Parkinson's disease. Parkinsonism & Related Disorders. 9: S83-9. PMID 12915072 DOI: 10.1016/S1353-8020(03)00022-1  0.32
2003 Vallines I, Bodis-Wollner I, Oezyurt J, Rutschmann RM, Greenlee MW. Perisaccadic V1 activity is not due to shifting visuo-spatial attention Journal of Vision. 3: 42a. DOI: 10.1167/3.9.42  0.32
2002 Bodis-Wollner I. Visualizing the next steps in Parkinson disease. Archives of Neurology. 59: 1233-4. PMID 12164717 DOI: 10.1001/archneur.59.8.1233  0.32
2002 Sartucci F, Tagliati M, Mylin LH, Bodis-Wollner I. Topographical analysis of the onset VEP in the detection of paracentral visual field defects. Clinical Eeg (Electroencephalography). 33: 62-9. PMID 12025733  0.32
2002 Bodis-Wollner I, Von Gizycki H, Avitable M, Hussain Z, Javeid A, Habib A, Raza A, Sabet M. Perisaccadic occipital EEG changes quantified with wavelet analysis. Annals of the New York Academy of Sciences. 956: 464-7. PMID 11960841  0.32
2002 Antal A, Kéri S, Dibó G, Benedek G, Janka Z, Vécsei L, Bodis-Wollner I. Electrophysiological correlates of visual categorization: evidence for cognitive dysfunctions in early Parkinson's disease. Brain Research. Cognitive Brain Research. 13: 153-8. PMID 11958957 DOI: 10.1016/S0926-6410(01)00090-8  0.32
2002 Bandini F, Pierantozzi M, Bodis-Wollner I. The visuo-cognitive and motor effect of amantadine in non-Caucasian patients with Parkinson's disease. A clinical and electrophysiological study. Journal of Neural Transmission (Vienna, Austria : 1996). 109: 41-51. PMID 11793161 DOI: 10.1007/s007020200003  0.32
2001 Bodis-Wollner I, Davis J, Tzelepi A, Bezerianos T. Wavelet transform of the EEG reveals differences in low and high gamma responses to elementary visual stimuli. Clinical Eeg (Electroencephalography). 32: 139-44. PMID 11512377  0.32
2001 Bandini F, Pierantozzi M, Bodis-Wollner I. Parkinson's disease changes the balance of onset and offset visual responses: an evoked potential study. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 112: 976-83. PMID 11377254 DOI: 10.1016/S1388-2457(01)00531-4  0.32
2001 Mari Z, Sagliocco L, Bodis-Wollner I. Retinocortical gain in the foveal pathway: the effect of spatial frequency and stimulus size. Clinical Eeg (Electroencephalography). 32: 67-74. PMID 11360723  0.32
2001 Antal A, Aita JF, Bodis-Wollner I. The paracentral visual field in multiple sclerosis: evidence for a deficit in interneuronal spatial summation? Vision Research. 41: 1735-42. PMID 11348654 DOI: 10.1016/S0042-6989(01)00051-7  0.32
2001 Bodis-Wollner I. The re-emergence of systems neuroscience Clinical Eeg Electroencephalography. 32: 96-97.  0.32
2000 Bodis-Wollner I, Brannan JR. Psychophysical examination of paracentral defects in glaucoma. Current Opinion in Ophthalmology. 11: 140-4. PMID 10848221 DOI: 10.1097/00055735-200004000-00013  0.32
2000 Tzelepi A, Bezerianos T, Bodis-Wollner I. Functional properties of sub-bands of oscillatory brain waves to pattern visual stimulation in man. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 111: 259-69. PMID 10680560 DOI: 10.1016/S1388-2457(99)00248-5  0.32
1999 Antal A, Kéri S, Bodis-Wollner I. L-alpha-glycerylphosphorylcholine enhances the amplitude of the pattern electroretinogram in rhesus monkeys. A pilot study. Neurobiology (Budapest, Hungary). 7: 407-12. PMID 10897800  0.32
1999 Bodis-Wollner I, Bucher SF, Seelos KC. Cortical activation patterns during voluntary blinks and voluntary saccades. Neurology. 53: 1800-5. PMID 10563631  0.32
1999 Bodis-Wollner IG, Paulus W. Visual and visual cognitive dysfunction in Parkinson's disease: spatial and chromatic vision. Advances in Neurology. 80: 383-8. PMID 10410745  0.32
1999 Stanzione P, Bodis-Wollner I, Pierantozzi M, Semprini R, Tagliati M, Peppe A, Bernardi G. A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 110: 82-5. PMID 10348324 DOI: 10.1016/S0168-5597(98)00047-1  0.32
1998 Antal A, Bandini F, Keri S, Bodis-Wollner I. Gastrointestinal dysfunction in Parkinson's disease Clinical Neuroscience. 5: 136-146. PMID 10785840  0.32
1998 Bodis-Wollner I, Tzelepi A. The push-pull action of dopamine on spatial tuning of the monkey retina: the effects of dopaminergic deficiency and selective D1 and D2 receptor ligands on the pattern electroretinogram. Vision Research. 38: 1479-87. PMID 9667012 DOI: 10.1016/S0042-6989(98)00028-5  0.32
1998 Peppe A, Antal A, Tagliati M, Stanzione P, Bodis-Wollner I. D1 agonist CY208-243 attenuates the pattern electroretinogram to low spatial frequency stimuli in the monkey. Neuroscience Letters. 243: 5-8. PMID 9535099 DOI: 10.1016/S0304-3940(98)00068-8  0.32
1998 Bodis-Wollner I, Fukuda Y, Spekreijse H, Wu SM. First Annual Conference in Association with Vision Research, 9-10 May 1997: Molecular, cellular and genetic approaches to function and dysfunction of the retina Vision Research. 38: 1313-1314. DOI: 10.1016/S0042-6989(98)00115-1  0.32
1998 Bodis-Wollner I, Pfeiffer RF. Clinical neuroscience: Introduction Clinical Neuroscience. 5: 61-62.  0.32
1997 Bodis-Wollner I. Vision and neurodegenerative diseases. Vision Research. 37: 3441-3. PMID 9425520  0.32
1997 Antal A, Kéri S, Bodis-Wollner I. Dopamine D2 receptor blockade alters the primary and cognitive components of visual evoked potentials in the monkey, Macaca fascicularis. Neuroscience Letters. 232: 179-81. PMID 9310309 DOI: 10.1016/S0304-3940(97)00596-X  0.32
1997 Sagliocco L, Bandini F, Pierantozzi M, Mari Z, Tzelepi A, Ko C, Gulzar J, Bodis-Wollner I. Electrophysiological evidence for visuocognitive dysfunction in younger non Caucasian patients with Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 104: 427-39. PMID 9295175 DOI: 10.1007/BF01277661  0.32
1997 Bodis-Wollner I, Brannan JR. Hidden visual loss in optic neuropathy is revealed using Gabor patch contrast perimetry. Clinical Neuroscience (New York, N.Y.). 4: 284-91. PMID 9292257  0.32
1997 Bodis-Wollner I. Optic nerve disease: an introduction. Clinical Neuroscience (New York, N.Y.). 4: 213-5. PMID 9292246  0.32
1997 Bodis-Wollner I, Bucher SF, Seelos KC, Paulus W, Reiser M, Oertel WH. Functional MRI mapping of occipital and frontal cortical activity during voluntary and imagined saccades. Neurology. 49: 416-20. PMID 9270570  0.32
1997 Bodis-Wollner I. Visual electrophysiology in Parkinson's disease: PERG, VEP and visual P300. Clinical Eeg (Electroencephalography). 28: 143-7. PMID 9241467  0.32
1997 Pfeiffer RE, Bodis-Wollner I. In reply Journal of the American Geriatrics Society. 45: 894-895. PMID 9215350 DOI: 10.1111/j.1532-5415.1997.tb01527.x  0.32
1997 Bodis-Wollner I. Neurodegenerative disease and optic neuropathy; the MPTP lesson Investigative Ophthalmology and Visual Science. 38: S246.  0.32
1997 Bandini F, Pierantozzi M, Sagliocco L, Bodis-Wollner I. Simultaneously evoked primary and cognitive visual evoked potentials reveal visuocognitive dysfunction in younger patients with Parkinson's Disease Italian Journal of Neurological Sciences. 18: 134.  0.32
1996 Bucher SF, Seelos KC, Bodis-Wollner I, Paulus W, Oertel WH, Reiser M. High resolution cortical activation mapping of voluntary eye movements using functional magnetic resonance imaging. Electroencephalography and Clinical Neurophysiology. Supplement. 47: 253-8. PMID 9335989  0.32
1996 Bodis-Wollner I. Electrophysiological assessment of retinal dopaminergic deficiency. Electroencephalography and Clinical Neurophysiology. Supplement. 46: 35-41. PMID 9059777  0.32
1996 Antal A, Pfeiffer R, Bodis-Wollner I. Simultaneously evoked primary and cognitive visual evoked potentials distinguish younger and older patients with Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 103: 1053-67. PMID 9013393 DOI: 10.1007/BF01291790  0.32
1996 Tagliati M, Bodis-Wollner I, Yahr MD. The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. Electroencephalography and Clinical Neurophysiology. 100: 1-11. PMID 8964257 DOI: 10.1016/0168-5597(95)00169-7  0.32
1996 Pfeiffer RF, Bodis-Wollner I. Charles Bonnet syndrome. Journal of the American Geriatrics Society. 44: 1128-9. PMID 8790248 DOI: 10.1111/j.1532-5415.1996.tb02955.x  0.32
1996 Ghosh SS, Fahy E, Bodis-Wollner I, Sherman J, Howell N. Longitudinal study of a heteroplasmic 3460 Leber hereditary optic neuropathy family by multiplexed primer-extension analysis and nucleotide sequencing. American Journal of Human Genetics. 58: 325-34. PMID 8571959  0.32
1996 Mari Z, Sagliocco L, Bodis-Wollner I. Pattern adaptation affects the phase of the PERG Investigative Ophthalmology and Visual Science. 37: S346.  0.32
1996 Bodis-Wollner I, Kleiner L. Spatial summation in the paracentral visual field in carriers of Leber's hereditary optic neuropathy Investigative Ophthalmology and Visual Science. 37: S922.  0.32
1995 Bodis-Wollner I, Antal A. On the functional significance of primate retinal dopamine receptors. Journal of Neural Transmission. Supplementum. 45: 67-74. PMID 8748611  0.32
1995 Bodis-Wollner I, Borod JC, Cicero B, Haywood CS, Raskin S, Mylin L, Sliwinski M, Falk A, Yahr MD. Modality dependent changes in event-related potentials correlate with specific cognitive functions in nondemented patients with Parkinson's disease. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 9: 197-209. PMID 8527004 DOI: 10.1007/BF02259661  0.32
1995 van Paesschen W, Mylin LH, Tagliati M, Sherman J, Bodis-Wollner I. Syphilitic perioptic neuritis in an HIV-seropositive patient: A case report and VEP study Neuro-Ophthalmology. 15: 271-275. DOI: 10.3109/01658109509044614  0.32
1994 Antal A, Kovanecz I, Bodis-Wollner I. Visual discrimination and P300 are affected in parallel by cholinergic agents in the behaving monkey. Physiology & Behavior. 56: 161-6. PMID 8084895 DOI: 10.1016/0031-9384(94)90274-7  0.32
1994 Howell N, Xu M, Halvorson S, Bodis-Wollner I, Sherman J. A heteroplasmic LHON family: tissue distribution and transmission of the 11778 mutation. American Journal of Human Genetics. 55: 203-6. PMID 8023847  0.32
1994 Tagliati M, Bodis-Wollner I, Kovanecz I, Stanzione P. Spatial frequency tuning of the monkey pattern ERG depends on D2 receptor-linked action of dopamine. Vision Research. 34: 2051-7. PMID 7941404 DOI: 10.1016/0042-6989(94)90316-6  0.32
1994 Bodis-Wollner I, Brannan JR. Assessment of Current visual psycho-physical testing methods with special reference to primary open angle glaucomatous disease (POAGD) Neuro-Ophthalmology. 14: 61-71. DOI: 10.3109/01658109409019488  0.32
1993 Bodis-Wollner I, Tagliati M. The visual system in Parkinson's disease. Advances in Neurology. 60: 390-4. PMID 8420159  0.32
1993 Sherman J, Bodis-Wollner I, Milch F, Goldstein J, Brannan J. Retinal periphlebitis in multiple sclerosis. Journal of the American Optometric Association. 64: 475-8. PMID 8376716  0.32
1993 Bodis-Wollner I, Tagliati M, Peppe A, Antal A. Visual and visual perceptual disorders in neurodegenerative diseases. BaillièRe's Clinical Neurology. 2: 461-91. PMID 8137009  0.32
1993 Antal A, Bodis-Wollner I. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview. Neurobiology (Budapest, Hungary). 1: 101-22. PMID 8111350  0.32
1993 Antal A, Bodis-Wollner I, Ghilardi MF, Glover A, Mylin L, Toldi J. The effect of levo-acetyl-carnitine on visual cognitive evoked potentials in the behaving monkey. Electroencephalography and Clinical Neurophysiology. 86: 268-74. PMID 7682930 DOI: 10.1016/0013-4694(93)90108-8  0.32
1993 Celesia GG, Bodis-Wollner I, Chatrian GE, Harding GF, Sokol S, Spekreijse H. Recommended standards for electroretinograms and visual evoked potentials. Report of an IFCN committee. Electroencephalography and Clinical Neurophysiology. 87: 421-36. PMID 7508376 DOI: 10.1016/0013-4694(93)90157-Q  0.32
1992 Howell N, McCullough D, Bodis-Wollner I. Molecular genetic analysis of a sporadic case of Leber hereditary optic neuropathy. American Journal of Human Genetics. 50: 443-6. PMID 1734726  0.32
1992 Brannan JR, Bodis-Wollner I, Storch RL. Evidence for two distinct nonlinear components in the human pattern ERG. Vision Research. 32: 11-7. PMID 1502796 DOI: 10.1016/0042-6989(92)90107-T  0.32
1992 Bodis-Wollner I. Sensory evoked potentials: PERG, VEP, and SEP. Current Opinion in Neurology and Neurosurgery. 5: 716-26. PMID 1392145  0.32
1992 Bodis-Wollner I, Brannan JR, Nicoll J, Frkovic S, Mylin LH. A short latency cortical component of the foveal VEP is revealed by hemifield stimulation. Electroencephalography and Clinical Neurophysiology. 84: 201-8. PMID 1375879 DOI: 10.1016/0168-5597(92)90001-R  0.32
1991 Bodis-Wollner I, Chung E, Ghilardi MF, Glover A, Onofrj M, Pasik P, Samson Y. Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 3: 63-72. PMID 2064731 DOI: 10.1007/BF02251137  0.32
1991 Aminoff MJ, Bodis-Wollner I, Chatrian GE, Chiappa KH, Emerson RG, Grundy BL, Klem GR, Legatt AD, Matsumiya Y, Rowe MJ, Streletz LJ, Yamada T. American electroencephalographic society guidelines for writing clinical evoked potential reports Journal of Clinical Neurophysiology. 8: 85-87. PMID 2019652  0.32
1991 Brannan JR, Bodis-Wollner I. Evidence for two systems mediating perceived contrast. Visual Neuroscience. 6: 587-92. PMID 1883763 DOI: 10.1017/S0952523800002571  0.32
1991 Glover A, Ghilardi MF, Bodis-Wollner I, Onofrj M, Mylin LH. Visual 'cognitive' evoked potentials in the behaving monkey. Electroencephalography and Clinical Neurophysiology. 80: 65-72. PMID 1703952 DOI: 10.1016/0168-5597(91)90045-Y  0.32
1991 Ghilardi MF, Sartucci F, Brannan JR, Onofrj MC, Bodis-Wollner I, Mylin L, Stroch R. N70 and P100 can be independently affected in multiple sclerosis. Electroencephalography and Clinical Neurophysiology. 80: 1-7. PMID 1703943 DOI: 10.1016/0168-5597(91)90035-V  0.32
1991 O’Brien CP, Bodis-Wollner I, Westheimer O. Conference abstracts: “advances in understanding the addictive states” Advances in Alcohol and Substance Abuse. 9: 133-141. DOI: 10.1080/J251v09n03_10  0.32
1990 Aine CJ, Bodis-Wollner I, George JS. Generators of visually evoked neuromagnetic responses. Spatial-frequency segregation and evidence for multiple sources. Advances in Neurology. 54: 141-55. PMID 2270800  0.32
1990 Raskin SA, Borod JC, Wasserstein J, Bodis-Wollner I, Coscia L, Yahr MD. Visuospatial orientation in Parkinson's disease. The International Journal of Neuroscience. 51: 9-18. PMID 2265914 DOI: 10.3109/00207459009000503  0.32
1990 Rubin GS, Bodis-Wollner I, Bullock JD, Holladay JT, Jaffe GF, Koch D, Lempert P, Mannis MJ, Marmor MF, Masket S, Miller D, Neumann AC, Regan DM, Richburg FA, Slonim CB, et al. Contrast sensitivity and glare testing in the evaluation of anterior segment disease Ophthalmology. 97: 1233-1237. PMID 2234858  0.32
1990 Bodis-Wollner I. Physiological effects of acetyl-levo-carnitine in the central nervous system. International Journal of Clinical Pharmacology Research. 10: 109-14. PMID 2201653  0.32
1990 Bodis-Wollner I. The visual system in Parkinson's disease. Research Publications - Association For Research in Nervous and Mental Disease. 67: 297-316. PMID 2106154  0.32
1990 Pang S, Borod JC, Hernandez A, Bodis-Wollner I, Raskin S, Mylin L, Coscia L, Yahr MD. The auditory P 300 correlates with specific cognitive deficits in Parkinson's disease. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 2: 249-64. PMID 2078307 DOI: 10.1007/BF02252920  0.32
1990 Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends in Neurosciences. 13: 296-302. PMID 1695407 DOI: 10.1016/0166-2236(90)90113-O  0.32
1990 Bodis-Wollner I, Hess RF, Zrenner E. Editorial Clinical Vision Sciences. 5: i.  0.32
1990 Lustgarten JS, Marx MS, Podos SM, Bodis-Wollner I, Campeas D, Serle JB. Contrast sensitivity and computerized perimetry in early detection of glaucomatous change Clinical Vision Sciences. 5: 407-413.  0.32
1989 Bodis-Wollner I. Electrophysiological and psychophysical testing of vision in glaucoma. Survey of Ophthalmology. 33: 301-7. PMID 2655143  0.32
1989 Berardi N, Bodis-Wollner I, Fiorentini A, Giuffré G, Morelli M. Electrophysiological evidence for interhemispheric transmission of visual information in man. The Journal of Physiology. 411: 207-25. PMID 2614724  0.32
1989 Ghilardi MF, Marx MS, Bodis-Wollner I, Camras CB, Glover AA. The effect of intraocular 6-hydroxydopamine on retinal processing of primates. Annals of Neurology. 25: 357-64. PMID 2496639 DOI: 10.1002/ana.410250407  0.32
1989 Bodis-Wollner I, Marx MS, Ghilardi MF. Systemic haloperidol administration increases the amplitude of the light- and dark-adapted flash ERG in the monkey Clinical Vision Sciences. 4: 19-26.  0.32
1989 Bobak P, Bodis-Wollner I, Guillory S, Anderson R. Aging differentially delays visual evoked potentials to checks and gratings Clinical Vision Sciences. 4: 269-274.  0.32
1988 Marx MS, Podos SM, Bodis-Wollner I, Lee PY, Wang RF, Severin C. Signs of early damage in glaucomatous monkey eyes: low spatial frequency losses in the pattern ERG and VEP. Experimental Eye Research. 46: 173-84. PMID 3350063 DOI: 10.1016/S0014-4835(88)80075-7  0.32
1988 Ghilardi MF, Chung E, Bodis-Wollner I, Dvorzniak M, Glover A, Onofrj M. Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. Life Sciences. 43: 255-62. PMID 3260986 DOI: 10.1016/0024-3205(88)90315-3  0.32
1988 Ghilardi MF, Bodis-Wollner I, Onofrj MC, Marx MS, Glover AA. Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain : a Journal of Neurology. 111: 131-49. PMID 3259150  0.32
1988 Bobak P, Bodis-Wollner I, Marx MS. Cortical contrast gain control in human spatial vision. The Journal of Physiology. 405: 421-37. PMID 3255797  0.32
1988 Glover A, Ghilardi MF, Bodis-Wollner I, Onofrj M. Alterations in event-related potentials (ERPs) of MPTP-treated monkeys. Electroencephalography and Clinical Neurophysiology. 71: 461-8. PMID 2460327 DOI: 10.1016/0168-5597(88)90050-0  0.32
1987 Celesia GG, Allison T, Bodis-Wollner I, Chatrian GE, Chiappa KH, Coats A, Cracco JB, Davis S, Grundy B, Matsumiya Y, Meng E, Raudzens P, Nuwer MR. American electroencephalographic society guidelines for intraoperative monitoring of sensory evoked potentials Journal of Clinical Neurophysiology. 4: 397-416. PMID 3680496  0.32
1987 Onofrj M, Ghilardi MF, Faricelli A, Bodis-Wollner I, Calvani M. Effect of levo-acetylcarnitine on P300-like potentials of the normal monkey. Drugs Under Experimental and Clinical Research. 13: 407-15. PMID 3652929  0.32
1987 Onofrj M, Bodis-Wollner I, Calvani M. Effect of L-acetyl carnitine HCl on rat steady-state visual evoked potentials. Comparison with L-carnitine. Drugs Under Experimental and Clinical Research. 13: 5-13. PMID 3595444  0.32
1987 Marx MS, Bodis-Wollner I, Lustgarten JS, Podos SM. Electrophysiological evidence that early glaucoma affects foveal vision. Documenta Ophthalmologica. Advances in Ophthalmology. 67: 281-301. PMID 3447853 DOI: 10.1007/BF00144282  0.32
1987 Ghilardi MF, Marx MS, Onofrj MC, Glover AA, Bodis-Wollner I. Scalp distribution of pattern visual evoked potentials in normal and hemianopic monkeys. Physiology & Behavior. 41: 297-302. PMID 3432382 DOI: 10.1016/0031-9384(87)90391-X  0.32
1987 Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain : a Journal of Neurology. 110: 1675-98. PMID 3427405  0.32
1987 Bobak P, Bodis-Wollner I, Guillory S. The effect of blur and contrast on VEP latency: comparison between check and sinusoidal and grating patterns. Electroencephalography and Clinical Neurophysiology. 68: 247-55. PMID 2439304 DOI: 10.1016/0168-5597(87)90045-1  0.32
1987 Bodis-Wollner I, Feldman RG, Guillory SL, Mylin L. Delayed visual evoked potentials are independent of pattern orientation in macular disease. Electroencephalography and Clinical Neurophysiology. 68: 172-9. PMID 2436876 DOI: 10.1016/0168-5597(87)90024-4  0.32
1987 Bodis-Wollner I, Mylin L. Plasticity of monocular and binocular vision following cerebral blindness: evoked potential evidence. Electroencephalography and Clinical Neurophysiology. 68: 70-4. PMID 2431893 DOI: 10.1016/0168-5597(87)90071-2  0.32
1986 Marx MS, Podos SM, Bodis-Wollner I, Howard-Williams JR, Siegel MJ, Teitelbaum CS, Maclin EL, Severin C. Flash and pattern electroretinograms in normal and laser-induced glaucomatous primate eyes. Investigative Ophthalmology & Visual Science. 27: 378-86. PMID 3949466  0.32
1986 Marx M, Bodis-Wollner I, Bobak P, Harnois C, Mylin L, Yahr M. Temporal frequency-dependent VEP changes in Parkinson's disease. Vision Research. 26: 185-93. PMID 3716211 DOI: 10.1016/0042-6989(86)90080-5  0.32
1986 Siegel MJ, Marx MS, Bodis-Wollner I, Podos SM. The effect of refractive error on pattern electroretinograms in primates. Current Eye Research. 5: 183-7. PMID 3698651 DOI: 10.3109/02713688609020041  0.32
1986 Heyer EJ, Simpson DM, Bodis-Wollner I, Diamond SP. Nitrous oxide: clinical and electrophysiologic investigation of neurologic complications. Neurology. 36: 1618-22. PMID 3024066  0.32
1986 Glover AA, Onofrj MC, Ghilardi MF, Bodis-Wollner I. P300-like potentials in the normal monkey using classical conditioning and an auditory 'oddball' paradigm. Electroencephalography and Clinical Neurophysiology. 65: 231-5. PMID 2420576 DOI: 10.1016/0168-5597(86)90058-4  0.32
1985 Bodis-Wollner I. Pattern evoked potential changes in parkinson’s disease are stimulus-dependent Neurology. 35: 1675-1676. PMID 4058761  0.32
1985 Onofrj M, Harnois C, Bodis-Wollner I. The hemispheric distribution of the transient rat VEP: a comparison of flash and pattern stimulation. Experimental Brain Research. 59: 427-33. PMID 4029318 DOI: 10.1007/BF00261332  0.32
1985 Bass SJ, Sherman J, Bodis-Wollner I, Nath S. Visual evoked potentials in macular disease. Investigative Ophthalmology & Visual Science. 26: 1071-4. PMID 4019098  0.32
1984 Bobak P, Bodis-Wollner I, Harnois C, Thornton J. VEPs in humans reveal high and low spatial contrast mechanisms. Investigative Ophthalmology & Visual Science. 25: 980-3. PMID 6746236  0.32
1984 Bodis-Wollner I, Yahr MD, Mylin LH. Nonmotor functions of the basal ganglia. Advances in Neurology. 40: 289-98. PMID 6695605  0.32
1984 Atkin A, Bodis-Wollner I, Wolkstein M, Podos S. Contrast sensitivity testing. The British Journal of Ophthalmology. 68: 63-4. PMID 6689937  0.32
1984 Harnois C, Bodis-Wollner I, Onofrj M. The effect of contrast and spatial frequency on the visual evoked potential of the hooded rat. Experimental Brain Research. 57: 1-8. PMID 6519219 DOI: 10.1007/BF00231126  0.32
1983 Bobak P, Bodis-Wollner I, Harnois C, Maffei L, Mylin L, Podos S, Thornton J. Pattern electroretinograms and visual-evoked potentials in glaucoma and multiple sclerosis. American Journal of Ophthalmology. 96: 72-83. PMID 6869481  0.32
1983 Atkin A, Bodis-Wollner I, Podos SM, Wolkstein M, Mylin L, Nitzberg S. Flicker threshold and pattern VEP latency in ocular hypertension and glaucoma. Investigative Ophthalmology & Visual Science. 24: 1524-8. PMID 6642932  0.32
1983 Bodis-Wollner I, Harnois C, Bobak P, Mylin L. On the possible role of temporal delays of afferent processing in Parkinson's disease. Journal of Neural Transmission. Supplementum. 19: 243-52. PMID 6321648  0.32
1982 Onofrj M, Bodis-Wollner I, Bobak P. Pattern visual evoked potentials in the rat. Physiology & Behavior. 28: 227-30. PMID 7079334 DOI: 10.1016/0031-9384(82)90066-X  0.32
1982 Bodis-Wollner I. Roundtable session: the true binocular visual evoked potential: introduction. Annals of the New York Academy of Sciences. 388: 608-9. PMID 6953890  0.32
1982 Bodis-Wollner I, Yahr MD, Mylin L, Thornton J. Dopaminergic deficiency and delayed visual evoked potentials in humans. Annals of Neurology. 11: 478-83. PMID 6125124 DOI: 10.1002/ana.410110507  0.32
1982 Bodis-Wollner I, Onofrj M, Mylin LH. VEP recovery in treated B12 deficiency Neurology. 32: A 204.  0.32
1981 Camisa J, Mylin LH, Bodis-Wollner I. The effect of stimulus orientation on the visual evoked potential in multiple sclerosis. Annals of Neurology. 10: 532-9. PMID 7325602 DOI: 10.1002/ana.410100607  0.32
1981 Bodis-Wollner I, Barris MC, Mylin LH, Julesz B, Kropfl W. Binocular stimulation reveals cortical components of the human visual evoked potential. Electroencephalography and Clinical Neurophysiology. 52: 298-305. PMID 6169506 DOI: 10.1016/0013-4694(81)90058-4  0.32
1981 Onofrj M, Bodis-Wollner I, Mylin L. Visual evoked potential latencies in papilledema and hydrocephalus Neuro-Ophthalmology. 2: 85-92. DOI: 10.3109/01658108109004926  0.32
1980 Braddick O, Atkinson J, Julesz B, Kropfl W, Bodis-Wollner I, Raab E. Cortical binocularity in infants. Nature. 288: 363-5. PMID 7432532 DOI: 10.1038/288363a0  0.32
1980 Atkin A, Wolkstein M, Bodis-Wollner I, Anders M, Kels B, Podos SM. Interocular comparison of contrast sensitivities in glaucoma patients and suspects. The British Journal of Ophthalmology. 64: 858-62. PMID 7426557 DOI: 10.1136/bjo.64.11.858  0.32
1980 Wolkstein M, Atkin A, Bodis-Wollner I. Contrast sensitivity in retinal disease. Ophthalmology. 87: 1140-9. PMID 7243206  0.32
1980 Bodis-Wollner I. Detection of visual defects using the contrast sensitivity function. International Ophthalmology Clinics. 20: 135-53. PMID 6995374  0.32
1980 Bodis-Wollner I, Korczyn AD. Dissociated sensory loss and visual evoked potentials in a patient with pernicious anemia. The Mount Sinai Journal of Medicine, New York. 47: 579-82. PMID 6971993  0.32
1979 Bodis-Wollner I. Visual implications of diagnostic advances in neurology. Journal of the American Optometric Association. 50: 89-92. PMID 762379  0.32
1979 Bodis-Wollner I, Hendley CD. On the separability of two mechanisms involved in the detection of grating patterns in humans. The Journal of Physiology. 291: 251-63. PMID 480212  0.32
1979 Atkin A, Bodis-Wollner I, Wolkstein M, Moss A, Podos SM. Abnormalities of central contrast sensitivity in glaucoma. American Journal of Ophthalmology. 88: 205-11. PMID 474692  0.32
1979 Bodis-Wollner I, Hendley CD, Mylin LH, Thornton J. Visual evoked potentials and the visuogram in multiple sclerosis. Annals of Neurology. 5: 40-7. PMID 426467 DOI: 10.1002/ana.410050107  0.32
1978 Bodis-Wollner I, Hendley CD, Mylin L, Thorton J. Visual evoked potential latency changes and losses of grating pattern detection in multiple sclerosis. Transactions of the American Neurological Association. 103: 163-5. PMID 757047  0.32
1978 Bodis-Wollner I, Yahr MD. Measurements of visual evoked potentials in Parkinson's disease. Brain : a Journal of Neurology. 101: 661-71. PMID 737524  0.32
1978 Bender MB, Bodis-Wollner I. Visual dysfunctions in optic tract lesions. Annals of Neurology. 3: 187-93. PMID 666260 DOI: 10.1002/ana.410030302  0.32
1977 Bodis-Wollner I, Atkin A, Raab E, Wolkstein M. Visual association cortex and vision in man: pattern-evoked occipital potentials in a blind boy. Science (New York, N.Y.). 198: 629-31. PMID 918658  0.32
1977 Friedland RP, Bodis-Wollner I. Absence of somatosensory evoked potentials in patients with anosognosia. Neurology. 27: 695-7. PMID 559980  0.32
1977 Bodis-Wollner I. Recovery from cerebral blindness: evoked potential and psychophysical measurements. Electroencephalography and Clinical Neurophysiology. 42: 178-84. PMID 65253 DOI: 10.1016/0013-4694(77)90024-4  0.32
1976 Bodis-Wollner IG, Pollen DA, Ronner SF. Responses of complex cells in the visual cortex of the cat as a function of the length of moving slits. Brain Research. 116: 205-16. PMID 974772 DOI: 10.1016/0006-8993(76)90900-8  0.32
1975 Bodis-Wollner I. Letter: Visual acuity measurements with grating patterns. Lancet. 2: 503-4. PMID 51316 DOI: 10.1016/S0140-6736(75)90579-6  0.32
1973 Bodis-Wollner I, Diamond SP. A method of testing and evaluating blurred vision in cerebral lesions. Transactions of the American Neurological Association. 98: 57-60. PMID 4784975  0.32
1972 Bodis-Wollner I. Visual acuity and contrast sensitivity in patients with cerebral lesions. Science (New York, N.Y.). 178: 769-71. PMID 5082844  0.32
1972 Bodis-Wollner I, Hendley CD, Kulikowski JJ. Electrophysiological and psychophysical responses to modulation of contrast of a grating pattern. Perception. 1: 341-9. PMID 4680937  0.32
1972 Bodis-Wollner I. Contrast sensitivity and increment threshold. Perception. 1: 73-83. PMID 4680927  0.32
Show low-probability matches.